 
 
 
November 21, 2025 
To, 
BSE Limited 
The General Manager-Listing  
Corporate Relationship Department, 
Ground Floor, P.J. Towers, 
Dalal Street, Mumbai 400001. 
 
Scrip Code: 539682 
 
 Subject: Outcome of Meeting of Board of Directors Held on Friday, November 21, 2025 
 
Dear Sir/Madam, 
 
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and 
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that 
Board of Directors of the Company, at its meeting held today, i.e. on Friday, November 21, 2025, 
inter-alia, considered and approved the following matters: 
 
1. Issue of equity shares on preferential basis 
 
Issue, offer and allot up to 9,19,117 (Nine Lakh Nineteen Thousand One Hundred 
Seventeen) equity shares of face value of Rs. 10/ - each, to persons other than Promoters 
(hereafter referred as “Proposed Allottees”), at a price of Rs. 1,088/ - (Rupees One 
Thousand Eighty Eight Only) per share (including a premium of Rs. 1,078/-), aggregating 
to Rs. 99,99,99,296/ - (Rupees Ninety Nine Crore Ninety Nine Lakh Ninety Nine 
Thousand Two Hundred Ninety Six only) by way of a preferential issue on a private 
placement bas is, subject to approval of the shareholders of the Company and in 
accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital 
and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”), as amended 
from time to time, the Companies Act, 2013 and other applicable laws and approvals from 
regulatory/ statutory authorities, as may be applicable. 
 
Details as required to be furnished under the Regulation 30 of Listing Regulations read 
with Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 
is enclosed herewith as Annexure A. 
  
 
 
 
2. Increase in authorized share capital of the Company 
 
Increase in authorized share capital of the Company from existing Rs. 16,00,00,000         
(Rupees Sixteen Crore only) divided into 1,60,00,000 Equity Shares of Rs. 10/- each to Rs. 
20,00,00,000/- (Rupees Twenty Crore only) divided into 2,00,00,000 Equity Shares of Rs. 
10/- each and consequent amendment in the Capital Clause (Clause V) of the 
Memorandum of Association of the Company, subject to the approval of shareholders of 
the Company. 
 
Details as required to be furnished under the Regulation 30 of Listing Regulations read 
with Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 
is enclosed herewith as Annexure B. 
 
3. Shifting of Registered Office of the Company from the State of Madhya Pradesh to the 
State of Maharashtra 
 
Shifting of Registered Office of the Company from the State of Madhya Pradesh located 
at 208, White Lotus Plaza, 1 Avantika Nagar, Scheme No. 51, Sangam Nagar, Army Head 
Quarter, Indore - 452006, Madhya Pradesh, India to the State of Maharashtra at Unit 111 
B Wing Western Edge II, Magathane, Borivali East, Mumbai - 400066, Maharashtra, India 
and consequent amendment in the Registered Office Clause (Clause II) of the 
Memorandum of Association of the Company, subject to the approval of shareholders. 
 
Details as required to be furnished under the Regulation 30 of Listing Regulations read 
with Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 
is enclosed herewith as Annexure B. 
 
4. Introduction and implementation of ‘Mobavenue AI Tech Limited Employee Stock 
Option Scheme 2025’ 
 
The Board of Directors, based on the recommendation of the Nomination and 
Remuneration Committee and in compliance with the provisions of SEBI (Share Based 
Employee Benefits and Sweat Equity) Regulations, 2021 (“SBEB Regulations”), considered 
and approved the implementation of Mobavenue AI Tech Limited Employee Stock Option 
 
 
 
Plan – ESOP 2025 (“ESOP 2025”/“Scheme”), subject to the approval of shareholders of 
the Company.  
 
Details as required to be furnished under the Regulation 30 of Listing Regulations read 
with Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 
is enclosed herewith as Annexure C. 
 
We request you to take the same on record. 
 
The Board Meeting commenced at 1:00 P.M. and concluded at 2:00 P.M. 
 
Yours faithfully, 
 
For Mobavenue AI Tech Limited 
(Formerly known as Lucent Industries Limited) 
 
 
 
____________________ 
Ishank Joshi 
Managing Director & Chief Executive Officer  
DIN: 05289924 
 
Encl.: A/a 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Annexure A 
 
Details as required to be furnished under the Regulation 30 of Listing Regulations read with 
Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 
Sr. 
No. 
Particulars Details 
1. Type of securities proposed to 
be issued 
Equity Shares of Rs. 10/- each fully paid-up 
2. Type of issuance Preferential Issue in accordance with Chapter V of 
SEBI ICDR Regulations read with the Companies 
Act, 2013 and rules made thereunder. 
3. Total number of securities 
proposed to be issued or the 
total amount for which the 
securities will be issued 
Up to 9,19,117 (Nine Lakh Nineteen Thousand One 
Hundred and Seventeen Only) Equity Shares 
having Face Value of Rs. 10/ - each at a price of Rs. 
1,088/- per Equity Share (including premium of Rs. 
1,078/- each) aggregating upto Rs. 99,99,99,296/-.  
4. In case of Preferential Issue, the following additional details to the Stock Exchange:  
i. Name of the Investors Sr. 
No. 
Name of the Proposed 
Allottees 
Maximum No. of 
Equity Shares to 
be issued 
1. Amit Mishra 1,33,088 
2. Pipal Capital 
Management Private 
Limited 
4,687 
3. Vinay Nagda 1,10,294 
4. Jayprakash Gupta 4,687 
5. Aman Shivraj Agro 
Industries Private 
Limited 
9,191 
6. AV Holdings 1,37,868 
7. Ratnatraya Holdings 45,956 
8. Vikram Sheth 4,596 
9. Shubhra Saxena 9,191 
10. M.J Construction 4,59,559 
TOTAL 9,19,117 
 
ii. Post Allotment of Securities: 
Outcome of Subscription 
Details of shareholding of the proposed allottees in 
the Company, prior to and after the proposed 
Preferential issue is as mentioned in Annexure A1 
 
 
 
iii. Issue Price Rs. 1,088/- per equity share 
iv. Number of Investors 10 (Ten) 
v. In case of convertibles, 
intimation on conversion of 
securities or on lapse of the 
tenure of the instrument 
Not Applicable 
5. Any cancellation or 
termination of proposal for 
issuance of securities including 
reasons thereof 
Not Applicable 
6. Object of the Issue The Board deliberated on the strategic deployment 
of the proposed preferential issue proceeds 
amounting to Rs. 99,99,99,296/- and approved the 
following utilization plan, aimed at driving 
sustainable growth, strengthening technological 
capabilities, and en hancing long -term shareholder 
value: 
 
~ 75% – Strategic Acquisition & Investments: 
 
To pursue a value -accretive acquisition aligned 
with the Company’s long -term vision, enabling 
expansion of our portfolio, strengthening market 
positioning, and accelerating revenue growth. 
 
~ 15% – Growth Expansion and Technological 
Advancements: 
 
To support expansion of core operations, scaling of 
business units, and advancement of technology 
initiatives, including development of new products, 
AI-driven solutions,  and digital transformation 
capabilities. 
 
~ 10% – General Corporate Purposes: 
 
General Corporate Purposes shall include, inter alia, 
day-to-day operational requirements, optimization 
of working capital, strengthening of the Company’s 
 
 
 
 
 
financial position, meeting routine corporate 
expenses, and any other purposes permitted under 
applicable laws, but shall exclude any payments 
towards buyback of securities, repayment of loans 
taken from the subscribers of the preferential issue, 
or any other end -uses restricted under SEBI 
regulations. 
 
The Board further resolved that progress will be 
closely monitored against defined milestones to 
ensure disciplined and timely execution. 
Management has been duly authorized to take all 
necessary actions for the effective implementation 
of the above initiatives. 
 
 
 
Annexure A1 
 
List of Proposed Allottees and their Shareholding prior and after the Preferential Issue 
 
 
 
 
  
Sr. 
No. 
Name of the 
Proposed 
Allottees 
Category Pre-issue 
holding 
(No. of 
shares) 
Pre-issue 
% 
holding 
No. of 
Equity 
Shares to 
be 
allotted 
Post-issue 
holding 
(No. of 
shares) 
Post-
issue % 
holding 
1. Amit Mishra Non-
Promoter 
0 0 1,33,088 1,33,088 0.84 
2. Pipal Capital 
Management 
Private Limited 
Non-
Promoter 
0 0 4,687 4,687 0.03 
3. Vinay Nagda Non-
Promoter 
48,000 0.32 1,10,294 1,58,294 0.99 
4. Jayprakash 
Gupta 
Non-
Promoter 
0 0 4,687 4,687 0.03 
5. Aman Shivraj 
Agro Industries 
Private Limited 
Non-
Promoter 
0 0 9,191 9,191 0.06 
6. AV Holdings Non-
Promoter 
0 0 1,37,868 1,37,868 0.87 
7. Ratnatraya 
Holdings 
Non-
Promoter 
0 0 45,956 45,956 0.29 
8. Vikram Sheth Non-
Promoter 
0 0 4,596 4,596 0.03 
9. Shubhra Saxena Non-
Promoter 
0 0 9,191 9,191 0.06 
10. M.J 
Construction 
Non-
Promoter 
0 0 4,59,559 4,59,559 2.89 
 
 
 
Annexure B 
 
Amendments to Memorandum of Association of the Company 
 
The Board of Directors of the Company at its Meeting held today i.e. Friday, November 21, 2025 
subject to approval of the Members, approved alteration of Registered Office Clause (Clause II) 
and Capital Clause (Clause V) of the Memorandum of Association of the Company as below: 
 
Clause II: 
 
The Registered office of the company will be situated in the State of Maharashtra. 
 
Clause V: 
 
The Authorised Share Capital of the Company is Rs. 20,00,00,000/ - (Rupees Twenty Crore only) divided 
into 2,00,00,000 (Two Crore) equity shares of Rs. 10/- (Rupees Ten only) each and with a power of increase 
or reduce the capital of the Company in accordance with the provisions of Companies Act, 2013.  
 
 
 
Annexure C 
 
Details as required to be furnished under the Regulation 30 of Listing Regulations read with 
Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 
 
Sr. 
No. 
Particulars Details 
1. Brief details of options granted The ESOP 2025 contemplates grant of employee 
stock options (“Options”) to the eligible employees 
of the Company and/ or subsidiary company(ies) 
of the Company. 
 
The ESOP 2025 aims to attract, retain, and motivate 
key employees by aligning their interests with the 
Company’s long -term growth. It rewards past 
performance, promotes future contribution, links 
compensation to individual and organizational 
achievements, and enables employees to benefit 
from the increase in the Company’s share value. 
 
A total of 7,50,000 options (not exceeding 5% of the 
paid up capital of the company as on 31 st March 
2025) have been approved for grant pursuant to 
ESOP Scheme 2025 to the eligible employees of the 
Company. 
2. Whether the scheme is in terms of 
SEBI (SBEB) Regulations, 2021 (if 
applicable) 
Yes 
 
3. Total number of shares covered 
by these options 
7,50,000 
4. Pricing formula The Options shall be granted at an Exercise Price 
determined by the Nomination and Remuneration 
Committee, which shall not be less than the face 
value of the Company’s equity shares and shall not 
exceed the Fair Market Value of the shares as on the 
date of grant. The Exercise Price shall also be in 
compliance with the accounting policies specified 
under Regulation 15 of the SBEB Regulations. 
 
 
 
5.  Options vested Not Applicable, as this outcome is pertaini ng to 
approval of the Scheme by the Board of Directors. 
6. Time within which option may be 
exercised 
The Exercise Period for vested Options shall be a 
maximum of 1 (One) year commencing from the 
relevant date of Vesting of Options, as determined 
by the Nomination and Remuneration Committee 
and shall be set out in the Grant Letter. In case of 
separation from employment, the Exercise Period 
shall be as set out in the ESOP Scheme 2025. 
7. Options exercised Not Applicable, as this outcome is pertaining to 
approval of the Scheme by the Board of Directors.  
 
8. Money realized by exercise of 
options 
9. The total number of shares arising 
as a result of exercise of option 
10. Options lapsed 
11. Variation of terms of options 
12. Brief details of significant terms As mentioned in the ESOP Scheme, 2025, which 
includes: 
 
1. The Nomination and Remuneration 
Committee shall administer the ESOP 2025. 
 
2. The Options granted under the ESOP 
Scheme 2025 shall vest not earlier than 1 
(one) year from the date of the grant (except 
in case of death or permanent incapacity) 
and not later than 4 (years) from the date of 
the grant. 
 
3. The maximum exercise period is 1 year from 
the date of vesting, subject to the terms of 
the ESOP 2025. 
 
4. A total of 7,50,000 options (not exceeding 5% 
of the paid up capital of the company as on 
31st March 2025) have been approved for 
grant pursuant to ESOP Scheme 2025 to the 
eligible employees of the Company. 
 
 
 
 
 
 
5. Shares arising on conversion of the Options 
will rank pari -passu with all other E quity 
Shares of the Company for the time being in 
issue.  The Shares arising out of exercise of 
Vested Options shall not be subject to any 
lock-in restriction except such restrictions as 
may be imposed pursuant to requirements 
under the Applicable Laws. Ea ch such 
Option conferring a right upon the 
Employee to apply for one Equity Share of 
the Company of face value of Rs. 10/ -, in 
accordance with the terms and conditions of 
such issue and subject to the provisions of 
ESOP 2025.  In case of any corporate acti on 
such as rights issue, bonus issue, merger, 
sale of division and others reasonable 
adjustments shall be made to the number of 
options in accordance with ESOP 2025. 
  
13. Subsequent changes or 
cancellation or exercise of such 
options 
Not Applicable, as t his outcome is pertaining to 
approval of the Scheme by the Board of Directors. 
14. Diluted earnings per share 
pursuant to issue of equity shares 
on exercise of options 
